Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

15 juin 2005 11h46 HE | Source: Delcath Systems

Delcath Reports on 2005 Annual Meeting

STAMFORD, Conn., June 15, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH) reported shareholders attending the company's 2005 annual meeting voted in favor of the re-election of Samuel...
09 juin 2005 08h45 HE | Source: Delcath Systems

Mid-Year 2005 Letter to Delcath Shareholders

STAMFORD, Conn., June 9, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH): Mid-Year Report To Our Stockholders: I am sure most of you are aware of the recent notice we received from the...
24 mai 2005 08h29 HE | Source: Delcath Systems

NCI'S Report on Initial Study of Delcath System in Current Issue of Journal of Clinical Oncology

STAMFORD, Conn., May 24, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH) said results of the National Cancer Institute's study of the company's system for delivering high-dose chemotherapy...
11 mai 2005 11h04 HE | Source: Delcath Systems

Delcath Receives Fast-Track Status from U.S. FDA for High Dose Cancer Treatment with Melphalan

STAMFORD, Conn., May 11, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH) said its novel system for delivering high dose chemotherapy to specific organs and body regions received fast-track...